TRIM73 is a tripartite motif-containing E3 ubiquitin ligase 1 with cytoplasmic localization and roles in innate immune response and protein ubiquitination. The gene arose through segmental duplication of TRIM50 during primate evolution, with structural divergence involving exon loss through homologous recombination 2. TRIM73 protein expression has been validated in human ovarian tissue at the single-cell level 3. Dysregulation of TRIM73 is associated with disease pathogenesis: skin biopsies from dermatomyositis patients show TRIM73 downregulation alongside upregulation of other TRIM family members and interferon signaling 4. Additionally, TRIM73 mutations have been identified in patients with secondary lung adenocarcinoma following breast cancer, suggesting involvement in malignancy-associated pathways including cytokine signaling and autophagy 5. TRIM73 variants have also been detected in cases of orofacial clefts with limb abnormalities, indicating potential roles in craniofacial and limb development 6. However, the specific molecular substrates and detailed functional mechanisms of TRIM73 remain incompletely characterized.